Arphing (Tommy) Lee

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when iSpecimen Inc. publishes a filing, an earnings call transcript or a press release.

Get ISPC alerts

About Arphing (Tommy) Lee

Arphing (Tommy) Lee is recorded as Board Member at iSpecimen Inc. (ISPC) since November 7, 2025. iSpecimen Inc. reported in an 8-K filed November 7, 2025 that Arphing (Tommy) Lee was appointed independent director, effective November 7, 2025. iSpecimen Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at iSpecimen Inc. includes Katharyn Field (CEO), Robert Bradley Lim (CEO and Board Member), Shahin Behroyan (CEO) and 7 others.

“In connection with Mr. Lim's resignation, the Board appointed Mr. Arphing (Tommy) Lee as an independent director to fill the resulting vacancy, effective immediately.”

iSpecimen Inc. Form 8-K, filed November 7, 2025 · Read the filing

Affiliation history

iSpecimen Inc. (ISPC)
Board Member

SEC 8-K

Current
2025-11-07–present

Company network

iSpecimen Inc.

ISPC

Current role

Diagnostics & Research · Healthcare

Board Member

2025-11-07–present

Leadership on record at iSpecimen Inc.

Katharyn Field CEO
Robert Bradley Lim CEO, Board Member
Shahin Behroyan CEO
Tracy Curley CEO, Board Member
Andrew L. Ross Chairman
Katherine (Katie) Field Chairman, Board Member
Richard Paolone Chairman, Board Member
Yuying Liang CFO
Anthony Lau Board Member
Avtar Dhaliwal Board Member

Recent activity

Executive change Appointed: independent director iSpecimen Inc. (ISPC)
2025-11-07